Log in to save to my catalogue

Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of...

Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808619452

Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy

About this item

Full title

Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy

Publisher

England: BMJ Publishing Group LTD

Journal title

Heart (British Cardiac Society), 2014-12, Vol.100 (23), p.1851-1858

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

Objective Myocardial fibrosis identified by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) in patients with hypertrophic cardiomyopathy (HCM) is associated with adverse cardiovascular events, but its value as an independent risk factor for sudden cardiac death (SCD) is unknown. We investigated the role of LGE-CMR in the r...

Alternative Titles

Full title

Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1808619452

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808619452

Other Identifiers

ISSN

1355-6037

E-ISSN

1468-201X

DOI

10.1136/heartjnl-2013-305471

How to access this item